New antagonists of the A
2B
adenosine receptor represented by formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of the A
2B
adenosine receptor.
本文披露了由公式(I)表示的A2B
腺苷受体的新
拮抗剂,以及它们的制备过程,包含它们的制药组合物和用作A2B
腺苷受体
拮抗剂的治疗用途。